Skip to main content

Day: June 28, 2023

Railroads reach agreement to create new direct connection and corridor linking Mexico, Texas and the U.S. Southeast

CALGARY, Alberta and JACKSONVILLE, Fla., June 28, 2023 (GLOBE NEWSWIRE) — Canadian Pacific Kansas City (TSX: CP) (NYSE: CP) (CPKC), CSX Corporation (NASDAQ: CSX) (CSX) and Genesee & Wyoming Inc. (G&W) today announced they have reached agreements that when completed will create a new direct CPKC-CSX interchange connection in Alabama. As part of the series of proposed transactions, CPKC and CSX would each acquire or operate portions of Meridian & Bigbee Railroad, L.L.C. (MNBR), a G&W-owned railway in Mississippi and Alabama, to establish a new freight corridor for shippers that connects Mexico, Texas and the U.S. Southeast. “This strategic acquisition will bring more shipping options to intermodal, automotive and other customers by providing a new, efficient corridor connecting expanding markets in Mexico, Texas...

Continue reading

Breckenridge Distillery Launches New Limited Release Collectors Art Series With Artist Sandra Fettingis

For its Third Annual Collectors Art Series, Breckenridge Distillery Partners with Local Colorado Artist to Create Label for its New, Limited Release, PX Naranja Cask Finish WhiskeyCollectors Art Series Third Collectors Art Series, a limited release of 96 proof PX Naranja Cask Finish WhiskeyBRECKENRIDGE, Colo., June 28, 2023 (GLOBE NEWSWIRE) — Breckenridge Distillery, one of the most awarded craft distilleries in the U.S., and winner of World’s Best Blended Whiskey, combines the art of blending whiskey and color through its third Collectors Art Series, a limited release of 96 proof PX Naranja Cask Finish Whiskey with a vibrant new label designed by local Colorado artist and muralist, Sandra Fettingis. For this third edition, Sandra brought her iconic geometric patterns to life through her inspiration for the flavorful craft...

Continue reading

GeneDx to Present New Data on Urine Mitochondrial DNA Testing at the 2023 United Mitochondrial Disease Foundation’s Mitochondrial Medicine Symposium

STAMFORD, Conn., June 28, 2023 (GLOBE NEWSWIRE) — GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic and clinical insights, today announced it will present new data on urine mitochondrial DNA testing at the 2023 United Mitochondrial Disease Foundation’s (UMDF) Mitochondrial Medicine Symposium in Charlotte, North Carolina, June 28 – July 1, 2023. Poster: Is the m.3243A>G variant detected in urine diagnostic for the patient’s disease?Presenter: Renkui Bai, M.D., Ph.D., FACMG, Director, Clinical Genetics at GeneDxDate/Time: Thursday, June 29, 2023, at 5:45 PM ET “Mitochondrial disease may be caused by genetic variants in DNA found in the nucleus of cells or by genetic variants in the body’s mitochondrial DNA (mtDNA). The m.3243A>G variant is found in the mitochondrial MT-TL1 gene and...

Continue reading

Cognition Therapeutics Announces Positive Topline Results for CT1812 Phase 2 SEQUEL Study for Mild-to-Moderate Alzheimer’s Disease

Results Show Positive Treatment Effect of CT1812 on Global and Regional Brain Activity Management Holding Webcast Conference Call at 8:00am ET Today NEW YORK, June 28, 2023 (GLOBE NEWSWIRE) — Cognition Therapeutics, Inc. (NASDAQ: CGTX), a clinical-stage neuroscience company developing drugs that treat age-related degenerative disorders by regulating cellular damage response pathways, today announced topline results from its Phase 2 double-blind, single-crossover SEQUEL study (NCT04735536) of CT1812 in 16 adults with mild-to-moderate Alzheimer’s disease. The study, which was conducted in the Netherlands, met its primary endpoints for safety and tolerability and showed positive effects for CT1812-treated participants as measured via quantitative electroencephalogram (qEEG). Research suggests that overall slowing of brain activity...

Continue reading

Roivant Reports Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2023, and Provides Business Update

RVT-3101 demonstrated improved efficacy results from the induction to chronic period in the TUSCANY-2 Phase 2b study in ulcerative colitis and was well tolerated with a favorable safety profile across all doses A Phase 2 study of RVT-3101 in Crohn’s disease has been initiated with topline data expected in the fourth quarter of calendar year 2024 VTAMA® (tapinarof) net product revenue was $13.7M for the quarter and $28.0M for the fiscal year ended March 31, 2023, with over 170,000 prescriptions written by approximately 11,000 unique prescribers since launch VTAMA® gross-to-net yield was 25% for the quarter ended March 31, 2023, and as of June 2023, coverage has been expanded to 125 million US commercial lives or 76% of total US commercial lives VTAMA® met the primary and all secondary endpoints in two Phase 3 studies ADORING 1 and 2, marking...

Continue reading

Hexagon Composites ASA: Minutes of Extraordinary General Meeting

28 June 2023: The extraordinary general meeting of Hexagon Composites ASA was held today, 28 June 2023 in Oslo, Norway. All proposals on the agenda were adopted as proposed. Complete minutes of the meeting are attached to this release and available on www.hexagongroup.com. For more information: Ingrid Aarsnes, VP Investor Relations & ESG, Hexagon Composites ASA Telephone: +47 950 38 364 | ingrid.aarsnes@hexagongroup.com About Hexagon Composites ASA Hexagon delivers safe and innovative solutions for a cleaner energy future. Our solutions enable storage, transportation and conversion to clean energy in a wide range of mobility, industrial and consumer applications. Learn more at www.hexagongroup.com and follow @HexagonASA on Twitter and LinkedIn. This information is subject to the disclosure requirements pursuant to Section 5-12...

Continue reading

Fit Soda™ Expands its Reach with 300 More Convenience Store Locations across the Southeast

DENVER and VANCOUVER, British Columbia, June 28, 2023 (GLOBE NEWSWIRE) — Koios Beverage Corp. (CSE: FIT; OTC: FITSF) (the “Company” or “Koios”) is elated to announce the successful expansion of Fit Soda™ into an additional 300 convenience store locations in Florida, South Carolina, North Carolina and Georgia, significantly increasing its presence in the market. With the inclusion of 300 more stores, Fit Soda™ is now proudly stocked in over 600 Circle K locations nationwide, demonstrating the successful growth and acceptance of Fit Soda™ within the Circle K community. Fit Soda™ continues its forward momentum with new placement in several Circle K stores, enhancing the brand’s footprint and availability to consumers. The beverage, known for its blend of tantalizing flavors...

Continue reading

Nasdaq Welcomed 60 IPOs in the First Half of 2023

Secured an 88% Win-Rate for Listings in the U.S. Market Two of the Three Largest Operating Company IPOs by Proceeds Raised Listed on Nasdaq NEW YORK, June 28, 2023 (GLOBE NEWSWIRE) — Nasdaq (Nasdaq: NDAQ) announced today that in the first half of 2023, it welcomed 60 initial public offerings (IPOs), raising a total of $3.71 billion. A total of 46 operating companies and 14 SPACs listed on Nasdaq during the first six months of 2023, representing an 88% win rate in the U.S. market, and extending Nasdaq’s leadership to 38 consecutive quarters. In addition to the IPOs, 4 companies transferred their corporate listing to Nasdaq. Additionally, Roper Technologies announced their intention to transfer their corporate listing to Nasdaq, representing $48 billion in market cap. “Nasdaq is committed to advocating on behalf of our issuers on...

Continue reading

Logistics Robots Market to Surpass 28.91 Billion by 2030 Drives Due to Growing Need for Personnel to Manage Logistics Operations

SkyQuest projects that the logistics robots market will attain a USD 28.91 billion value by 2030, with a CAGR of 16.7% over the forecast period (2023-2030).The market demand for logistics robots is expected to be driven by the increased emphasis on end-to-end automation to achieve operational efficiency and address challenges related to workforce availability. One of the primary factors contributing to this demand is the growing need for personnel to manage logistics operations, particularly in the expanding e-commerce sectors. Westford,USA, June 28, 2023 (GLOBE NEWSWIRE) — According to SkyQuest, the logistics robots market growth is influenced by several significant factors. Firstly, there is an increasing need for safety measures in the workplace, driving the adoption of robotics to minimize risks and protect workers. Logistics...

Continue reading

Hexatronic signs an agreement to acquire Fibron from Rubicon Partners and strengthens its position in Harsh Environments

Press release June 28, 2023Gothenburg, Sweden Hexatronic signs an agreement to acquire Fibron from Rubicon Partners and strengthens its position in Harsh Environments Hexatronic Group AB (publ) (“Hexatronic”) has signed an agreement to acquire Fibron BX, LTD (“Fibron”), a leading original equipment manufacturer within harsh environment electro-optical cables from Rubicon Partners. By acquiring Fibron, Hexatronic will strengthen its position as a comprehensive provider of high-quality umbilical products and specialty underwater cables. Fibron’s diverse portfolio delivers across sectors such as traditional energy markets including renewables (wave, tidal & wind), ROV, defense, and diving and their extensive global customer base complements Hexatronic’s existing portfolio. The estimated enterprise value amounts to GBP 32...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.